Richard Yue

Novotech China

Novotech has built on our deep experience and coverage across Asia-Pacific with expansion into North America and Europe to provide global clinical development support to our global client base. Novotech has offices in 14 geographies across Asia-Pacific, South Africa and North America., site partnerships with over 45 key medical institutions and experience with >1700 clinical trial sites Novotech provides clinical development services across all clinical trial including regulatory and drug development consulting, protocol design and writing, feasibility assessments, local ethics committee and regulatory submissions, clinical monitoring, project and vendor management, data management, statistical analysis, data visualization and analytics, DCTs, medical advisory and medical monitoring, pharmacovigilance, central lab services and clinical study report writing. We work to the highest quality standards, in line with ICH-GCP, global regulatory agencies and underpinned by robust processes in line with our ISO 9001 accredited Quality Management system. Novotech has broad therapeutic experience with a particular focus on oncology/immuno-oncology, infectious disease/vaccines, neurology, and rare diseases. As a biotech specialist, Novotech has extensive medical, scientific, regulatory, and operational expertise with advanced and novel therapeutics, across all therapeutic areas, including cell & gene therapies, precision medicine, RNA based vaccines and therapeutics, ADCs, microbiome, radiopharmaceuticals and more. Our geographic presence, our depth of expertise and services, our operational infrastructure, and investments in technological advancements, combine to provide the perfect solution to accelerate global clinical development for biotech Sponsors.